Form 4: Cryoport CFO Exercises Options, Sells Shares

Cryoport's Chief Financial Officer, Robert Stefanovich, exercised stock options and subsequently sold a portion of the acquired shares to cover the exercise cost.

Summary

• Robert Stefanovich, Cryoport's Chief Financial Officer, acquired 26,164 shares of Common Stock on August 19, 2025, through the exercise of stock options at an exercise price of $3.07 per share.
• On the same date, Mr. Stefanovich disposed of 9,300 shares of Common Stock at a weighted average price of $8.6686 per share, with prices ranging from $8.60 to $8.75.
• The proceeds from the sale of these 9,300 shares were used to cover the exercise price of the stock options.
• Following these transactions, Mr. Stefanovich beneficially owns 207,213 shares of Cryoport Common Stock.
• The options exercised had a vesting schedule of 1/48 per month for 48 months, beginning August 19, 2015.

Sentiment

Score: 5

Explanation: The filing details a routine insider transaction (exercise of options and sell-to-cover) which is common for executives. It does not inherently signal strong positive or negative sentiment about the company's future performance, thus a neutral score is appropriate.

Positives

• The exercise of stock options by the Chief Financial Officer indicates that the options were in-the-money, suggesting the stock price has appreciated since the options were granted.
• The exercise price of $3.07 is significantly lower than the sale price of $8.6686, indicating a substantial gain for the insider on the exercised shares.

Negatives

• The sale of 9,300 shares, even if for tax or exercise cost purposes, reduces the direct ownership stake of a key executive in the company.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The transaction is a routine insider activity and is unlikely to have a significant direct impact on shareholders, beyond providing transparency into executive stock holdings.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request to Cryoport, Inc., any security holder, or the SEC staff.

Key Dates

Recommendation

The filing details a routine insider transaction where the CFO exercised vested stock options and sold a portion of the acquired shares to cover the exercise price and taxes. This 'sell-to-cover' action is common and does not necessarily indicate a change in the company's fundamental outlook or the insider's long-term confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Cryoport, CYRX, Form 4, Insider Trading, Stock Options, CFO, Robert Stefanovich, Share Sale, Equity, Beneficial Ownership